|
1
|
Bynum SA, Brandt HM, Sharpe PA, Williams
MS and Kerr JC: Working to close the gap: identifying predictors of
HPV vaccine uptake among young African American women. J Health
Care Poor Underserved. 22:549–561. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang XC and Wu MY: Progress. on
DC-CIK-based adoptive cellular immunotherapy for uterine cervical
neoplasm. Guangdong Yao Xue Yuan Xue Bao. 29:575–579. 2013.(In
Chinese).
|
|
3
|
Tewari KS and Monk BJ: New strategies in
advanced cervical cancer: from angiogenesis blockade to
immunotherapy. Clin Cancer Res. 20:5349–5358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang FS, Liu MX, Zhang B, et al: Antitumor
activities of human autologous cytokine-induced killer (CIK) cells
against hepatocellular carcinoma cells in vitro and in vivo. World
J Gastroenterol. 8:464–468. 2002.PubMed/NCBI
|
|
5
|
Itsumi M and Tatsugami K: Immunotherapy
for renal cell carcinoma. Clin Dev Immunol. 2010:2845812010.
View Article : Google Scholar
|
|
6
|
Kim HM, Lim J, Kang JS, et al: Inhibition
of human cervical carcinoma growth by cytokine-induced killer cells
in nude mouse xenograft model. Int Immunopharmacol. 9:375–380.
2009. View Article : Google Scholar
|
|
7
|
Hontscha C, Borck Y, Zhou H, Messmer D and
Schmidt-Wolf IG: Clinical trials on CIK cells: first report of the
international registry on CIK cells (IRCC). J Cancer Res Clin
Oncol. 137:305–310. 2011. View Article : Google Scholar
|
|
8
|
Palucka K and Banchereau J: Cancer
immunotherapy via dendritic cells. Nat Rev Cancer. 12:265–277.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bhargava A, Bunkar N, Khare NK, Mishra D
and Mishra PK: Nanoengineered strategies to optimize dendritic
cells for gastrointestinal tumor immunotherapy: from biology to
translational medicine. Nanomedicine (Lond). 9:2187–2202. 2014.
View Article : Google Scholar
|
|
10
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kastritis E, Bamias A, Bozas G, et al: The
impact of age in the outcome of patients with advanced or recurrent
cervical cancer after platinum-based chemotherapy. Gynecol Oncol.
104:372–376. 2007. View Article : Google Scholar
|
|
12
|
Motz GT and Coukos G: Deciphering and
reversing tumor immune suppression. Immunity. 39:61–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lindau D, Gielen P, Kroesen M, Wesseling P
and Adema GJ: The immunosuppressive tumour network: myeloid-derived
suppressor cells, regulatory T cells and natural killer T cells.
Immunology. 138:105–115. 2013. View Article : Google Scholar :
|
|
14
|
Hasan UA, Bates E, Takeshita F, et al:
TLR9 expression and function is abolished by the cervical
cancer-associated human papillomavirus type 16. J Immunol.
178:3186–3197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Yu W, Li H, Yu J, Zhang X, Ren X
and Cao S: Can the dual-functional capability of CIK cells be used
to improve antitumor effects? Cell Immunol. 287:18–22. 2014.
View Article : Google Scholar
|
|
16
|
Wang QJ, Wang H, Pan K, et al: Comparative
study on anti-tumor immune response of autologous cytokine-induced
killer (CIK) cells, dendritic cells-CIK (DC-CIK) and
semi-allogeneic DC-CIK. Chin J Cancer. 29:641–648. 201
|
|
17
|
Zheng YW, Li RM, Zhang XW and Ren XB:
Current adoptive immunotherapy in non-small cell lung cancer and
potential influence of therapy outcome. Cancer Invest. 31:197–205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ren J, Di L, Song G, Yu J, et al:
Selections of appropriate regimen of high-dose chemotherapy
combined with adoptive cellular therapy with dendritic and
cytokine-induced killer cells improved progression-free and overall
survival in patients with metastatic breast cancer: reargument of
such contentious therapeutic preferences. Clin Transl Oncol.
15:780–788. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang HZ, Shi N, Li LN, Kang H and Yang LN:
Clinical research of interventional treatment combined with CIK in
patients with uterine cervix cancer. Haerbin Yi Ke Da Xue Xue Bao.
44:263–266. 2010.(In Chinese).
|
|
20
|
Zhu YH, Liu JQ, Cao H, et al: Clinical
efficiency of radiotherapy combined with self-immune cell therapy
for cervical carcinoma. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za
Zhi. 19:421–427. 2012.(In Chinese).
|
|
21
|
Laurin D, Marin V, Biagi E, et al:
Exploration of the lysis mechanisms of leukaemic blasts by
chimaeric T-cells. J Biomed Biotechnol. 2010:2345402010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hackstein H and Thomson AW: Dendritic
cells: emerging pharmacological targets of immunosuppressive drugs.
Nat Rev Immunol. 4:24–34. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang L, Ren B, Li H, Yu J, Cao S, Hao X
and Ren X: Enhanced antitumor effects of DC-activated CIKs to
chemotherapy treatment in a single cohort of advanced
non-small-cell lung cancer patients. Cancer Immunol Immunother.
62:65–73. 2013. View Article : Google Scholar
|
